 Avacta Group plc LON:AVCT, the developer of Affimer biotherapeutics and reagents, has announced that it has appointed BBI Solutions, part of BBI Group, to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva. BBI Solutions is a leading global developer and manufacturer of raw materials and finished test products for the in-vitro ... 